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Although a causal link between chronic inflammation and cancer has been established,
the exact molecular mechanism linking inflammation to cancer remains largely unknown.
It was previously postulated that molecular switches responsible for cancer cell
development, and for infiltration of inflammatory cells into cancer, were divided into a
distinct set of intracellular proteins and signaling pathways. However, recent evidence
suggests that both tumor cells and tumor-infiltrating immune cells utilize the same kinases,
mostly that of Src family, to facilitate cancer development and progression. In the past few
years several groups have found that Src activation both in cancer and inflammatory cells is
mainly driven by pro-inflammatory cytokines within the tumor microenvironment. Here we
evaluate the cross talks between Src kinase pathways in immune cells and cancer cells.
We conclude that Src might serve as a critical mechanistic link between inflammation
and cancer, mediating and propagating a cycle between immune and tissue cells that can
ultimately lead to the development and progression of cancer.
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INTRODUCTION
Inflammation is a vital defensive response that serve critical
roles in a variety of physiological situations, and when dysreg-
ulated, can contribute to the pathogenesis of many diseases.
Chronic inflammation is a well-documented risk for promot-
ing cancer (Coussens and Werb, 2002; Balkwill et al., 2005;
Mantovani et al., 2008), particularly in the pancreas and GI
tract (Guerra et al., 2007; Terzic´ et al., 2010). Chronic pancre-
atitis is long-standing inflammation of the pancreas associated
with an increased risk (∼20-fold) for pancreatic cancer. This
projects a serious clinical problem as pancreatic cancer is a highly
lethal disease with the worst prognosis of all the major malig-
nancies; for all stages combined, and a 5-year survival rate of
5% (Yadav et al., 2011). Similarly, uncontrolled inflammatory
bowel disease poses a significant risk factor for colorectal can-
cer. When compared to the general population matched for age,
sex, and years at risk, there is a 18-fold increase in Crohn’s dis-
ease and a 19-fold increase in ulcerative colitis, (Bernstein et al.,
2001; Eaden et al., 2001; Itzkowitz and Yio, 2004; Ullman and
Itzkowitz, 2011). Interestingly, many environmental cancer risk
factors, including alcohol overuse, smoking, chronic infections
and obesity, can trigger some form of chronic inflammation,
largely in the pancreas and colon (Trinchieri, 2012). These envi-
ronmental risk factors seemingly facilitate the development and
progression of cancer mostly through the induction of chronic
persistent inflammation in these tissues.
Although many studies point to an association between
inflammation and cancer, the mechanistic signaling basis of
Abbreviations: LPS, lipopolysaccharides; TNF-α, tumor necrosis factor; IL-1,
interleukine 1; IL-6, interleukine 6; MCP-1, monocyte chemoattractant protein-
1; MIP-1, macrophage inflammatory protein 1; MIP-2, macrophage inflamma-
tory protein 2; SDF-1, stromal cell-derived factor 1; PI3K, phosphatidylinositol-3
kinase.
this linkage is not well understood. The importance of Src
family kinases in colon and pancreatic cancer development is
known for many years and is well established (Staley et al.,
1997; Lutz et al., 1998; Aligayer et al., 2002). Recent evi-
dence has shown that Src signaling network is also very
important in movement and infiltration of immune cells into
tumor (Balkwill, 2004; Kulbe et al., 2004). Several groups have
found that Src activation in cancer and immune inflamma-
tory cells are mediated by inflammatory cytokines within the
tumor microenvironment. Given that Src is overactive in both
tumor cells and in tumor-infiltrating immune cells, and is also
involved in cytokine-mediated cross talk between cancer and
inflammatory cells—Src may be a critical link between inflam-
mation and cancer. We illustrate and expound on this con-
cept using the model of chronic pancreatitis and pancreatic
cancer.
PERSISTENT INFLAMMATION INCREASES CANCER RISK
IN PANCREAS
Chronic pancreatitis highlights an important role for chronic
inflammation in the development of cancer. Chronic pancreati-
tis is the most consistent risk factor for pancreatic cancer and
alone increases the risk of developing pancreatic cancer by 10–20-
fold (Díteˇ et al., 2012). Many of the environmental cancer risk
factors can initially induce chronic inflammation that subse-
quently leads to pancreatic cancer. Recurrent pancreatic injury
from alcohol abuse, smoking, high-fat diet, diabetes, and genetic
predisposition, induces a pro-inflammatory environment con-
sisting of various types of immune cells, cytokines, chemokines,
and growth factors that, when dysregulated and persistent, can
ultimately lead to the development and progression of cancer
(Lowenfels et al., 2001; Shoelson et al., 2007; Pannala et al., 2009;
Momi et al., 2012).
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Alcohol abuse is a major cause of acute and chronic pancre-
atitis. The disease usually presents as an acute episode of pan-
creatitis and progress with additional exacerbations that can lead
to chronic pancreatitis, characterized by a sequence of necrotic
and fibrotic events. The initial tissue injures are associated
with cytokine release during necro-inflammation and appears to
include premature intracellular activation of digestive enzymes,
leading to autodigestion. Alcohol metabolism causes release of
endogenous hydrolases from pancreatic lysozymes, which are
responsible for premature activation of trypsinogen leading to
intrapancreatic autodigestion and inflammation (Talamini et al.,
1999). Reactive oxygen species generated results in further pan-
creatic tissue injury, and further release of pro-inflammatory
cytokines and chemokines (Shi et al., 2005).
In addition, alcohol when combined with cigarette smoking
exacerbates the chronic inflammatory process (Go et al., 2005;
Maisonneuve et al., 2005; Wis´niewska et al., 2013). Cigarette
smoking contributes to the development of chronic pancreati-
tis by inducing cytokine release and inflammation. Smoking is
the major risk factor for the development of pancreatic can-
cer accounting for 20–30% of cases (Lowenfels et al., 2001). In
experimental models, nicotine stimulated an acute inflammatory
reaction in the pancreas, which progressed to chronic pancreati-
tis after repeated sessions of smoking-induced acute pancreatic
inflammation. These nicotine-induced inflammatory events are
clearly associated with the release of pro-inflammatory cytokines
(Nordskog et al., 2003).
Both central and overall obesity are associated with increased
risk for pancreatic cancer (Pannala et al., 2009). Although the
exact mechanism of obesity to pancreatic cancer is unclear, the
major issues revolve around chronic inflammation, glucose intol-
erance, hyperinsulinemia, insulin resistance, and oxidative stress.
Inflammation, along with the immune system plays a vital role
in the development of insulin resistance, diabetes, and ulti-
mately pancreatic cancer. Adipose tissue is involved in the release
of cytokines and chemokines including TNF-α, IL-6, MCP-1,
CXCL12, CCL5, CCL20, that lead to the recruitment of pro-
inflammatory cells into adipose tissue (Shoelson et al., 2007; Sell
et al., 2012). Obese individuals also exhibit lower circulating lev-
els of anti-inflammatory adipokines that sustains a low-grade
systemic inflammation.
Hereditary pancreatitis is a rare autosomal dominant con-
dition caused by gain-of-function mutations in the cationic
trypsinogen gene (PRSS1) and is responsible for<1% of all forms
of pancreatitis. Mutant PRSS1 gene causes premature activation
or impairs the deactivation of trypsin leading to recurrent injury,
cytokine release, and inflammation. The risk of developing pan-
creatic cancer is 53 times higher when compared to the risk in
unaffected individuals. Of the patients who progress to chronic
pancreatitis, the risk of developing pancreatic cancer by age 70
years is approximately 40%. Pancreatic inflammation also occurs
at a much younger age in this group of patients. In addition,
Lowenfels et al. reported a 2-fold increased risk of developing
pancreatic cancer in smokers with hereditary pancreatitis as com-
pared to non-smokers. Pancreatic cancer also developed 20 years
earlier in smokers than in non-smokers (Howes et al., 2004;
Rebours et al., 2009), suggesting that nicotine-induced release of
cytokines and inflammation can rapidly accelerate the promotion
and development of cancer in these patients.
INFLAMMATORY CELLS INFILTRATE TUMOR IN PANCREAS
Since the role of various immune cells (including lymphocytes,
granulocytes, and macrophages) in pancreatic inflammation and
cancer has been discussed elsewhere (Mantovani et al., 2008),
this review will focus on studies of macrophages as Src kinase-
dependent and cytokine-mediated linkage between inflammation
and cancer seems most apparent in these cells. Tumor-associated
macrophages are key players in pancreatic inflammation and can-
cer and an important source of cytokines (Feig et al., 2012; Liou
et al., 2013). As described above, chronic pancreatitis is often
initiated by environmental risk factors, leads to permanent dam-
age of pancreas, and is a consistent risk factor for pancreatic
cancer. Chronic pancreatitis is characterized by marked stroma
formation with a high number of infiltrating macrophages and
myofiroblastic-like stellate cells, which are believed to play a
central role in initiating inflammation and disease progression
(Erkan et al., 2012). In response to pancreatic injury (alcohol
abuse, cigarette smoking, obesity, mutations in genetically pre-
disposed persons, etc.), inflammatory signals and chemokines
production are upregulated leading to infiltration of leukocytes
and stellate cells to the damaged acinar cells. Inflammatory
cells that are recruited in turn secrete several cytokines, includ-
ing chemokines, interleukins, and interferons, that contribute to
cancer growth, invasion, and metastasis (Figure 1, Table 1).
Numerous experimental studies have suggested an important
role of macrophages in generating the microenvironment for
both chronic pancreatitis and tumor cells, thus highlighting a
similarity between stroma composition in chronic pancreatitis
and pancreatic cancer. Macrophages are derived from circu-
lating peripheral monocytes mostly in response to chemokine
monocyte chemoattractant protein 1 (MCP-1). Several other
chemokines, including MIP-1, MIP-2, and SDF-1, are also
increased at the site of inflammation attracting leukocytes and
tissue precursors to the injured pancreas (Spaeth et al., 2008).
In turn, macrophages, other leukocytes, and stellate cells, which
all infiltrate the tumor, release cytokines, including IL-1, IL-6
and TNF that directly effect cancer cell proliferation, and move-
ment/attachment. This process promotes cancer development
and progression (Figure 1, Table 1). It is also possible that the
cytokine-mediated persistent activation of certain key intracel-
lular signaling pathways, which occurs during chronic inflam-
mation, might inhibit apoptosis and prevent the elimination of
genetically altered, precancerous and cancerous cells.
Src ACTIVATION CONTRIBUTES TO BOTH INFLAMMATION
AND CANCER IN PANCREAS
Src was the first transforming protein discovered and isolated
(Rous, 1911; Stehelin et al., 1976; Brugge and Erikson, 1997)
and was also the first gene product with protein tyrosine kinase
activity (Hunter and Sefton, 1980). The Src family kinases com-
prise of nine non-receptor protein tyrosine kinases that share
similar structure and function. Src family kinases have a crit-
ical role in cell adhesion, proliferation, survival, and invasion,
including cell movement, and activation of cytokine receptors.
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FIGURE 1 | Src-dependent cross talk between inflammatory and cancer
cells. Src activation is driven in both inflammatory cells and cancer cells by
pro-inflammatory cytokines within the tumor microenvironment. Activation of
Src kinases in immune cells by tumor-secreted cytokines (chemokines:
SDF-1, MIP-1, MCP-1, MIP-2, etc.) induces production of cytokines (TNF-a,
IL-1b, IL-6, etc.) that reciprocally activate Src in cancer cells to promote cancer
progression and to induce more cytokine (chemokine) that attract more
inflammatory cells into the tumor. Thus, a Src-dependent condition exists in
which one problem causes another problem that makes the first problem
worse (vicious cycle).
Table 1 | Src tyrosine kinase family and cytokine/chemokine interaction in immune and cancer cells.
Src TYROSINE KINASE FAMILY MEDIATE CYTOKINE/CHEMOKINE PRODUCTION
Src kinase family Cytokines/chemokines Source References
Src MIP-1α, MCP-1, MIP-2 Acinar cells Ramnath et al., 2009
Lyn TNF-α Macrophages Tomkowicz et al., 2006
Hck TNF-α, IL-6 Colorectal cancer Smolinska et al., 2011
Src TNF-α, IL-6 Macrophages Sarang et al., 2011
Lyn IL-1β Macrophages Cheung et al., 2008
CYTOKINES ACTIVATE Src TYROSINE KINASE FAMILY
Cytokines Src kinase family Source
TNF-α Src Acinar cells Satoh et al., 2005
IL-6 Src Gastric cancer cells Lin et al., 2007
IL-6 Hck Myeloma cells Podar et al., 2004
IL-6 Fyn, Lyn Hck Myeloma cells Hallek et al., 1997
CHEMOKINES ACTIVATE Src TYROSINE KINASE FAMILY
Chemokines Src kinase family Source
SDF-1 Src Ductal cells Kayali et al., 2003
SDF-1 Lyn Macrophages Malik et al., 2008
SDF-1 Lyn B lymphocytes Nakata et al., 2006
SDF-1 Lck T lymphocytes Inngjerdingen et al., 2002
MIP-1-β Lyn Macrophages Tomkowicz et al., 2006
RANTES Lyn Macrophages Cheung et al., 2009
Numerous groups have found that hyper-activation and/or over-
expression of Src family kinases are critical to various types of
cancers.
Expression of several members of the Src-family tyrosine
kinases, including Src, Fyn, Yes, Fgr and Lyn has been demon-
strated in pancreatic cancer cell lines and primary cells. The
expression of Lyn kinase is the most abundant in these cells
(Fu et al., 2006). Numerous studies have shown that elevated
Src-family kinase activity in human pancreatic carcinomas (when
compared to normal pancreatic cells) not only contributes to pan-
creatic cancer growth, but also to invasion and metastasis (Lutz
et al., 1998; Trevino et al., 2006; Yokoi et al., 2011). Src kinases
and oncogenic Ras, PI3K, p38MAPK and Dynamin-2 have been
shown to co-operatively stimulate the growth, metastatic migra-
tion and invasion of pancreatic carcinoma (Summy et al., 2005;
Shields et al., 2011).
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Src activation has been observed in circulating blood mono-
cytes and tissue macrophages in chronic pancreatitis, as well as in
tumor-associated macrophages and acinar cells in pancreatic can-
cer (Yokoi et al., 2011). Elevated level of activity of Src in inflam-
matorymonocytes/macrophages was proposed as a biomarker for
pancreatic cancer (Coppola, 2000; Yokoi et al., 2011). However,
no oncogenic mutations responsible for Src activation in inflam-
matory and cancer cells in the pancreas have yet been identified.
Thus, Src activation is likely a result of underlying inflamma-
tion and the consequence of a cytokine-mediated inflammatory
microenvironment during malignant transformation and pro-
gression. It seems that the signal activating Src kinases is within
the inflammatory microenvironment without the necessity of
the Src mutation. Consequently, several groups have found that
Src activation is driven by pro-inflammatory cytokines, and
inversely, the cytokine production is driven by Src kinases, in var-
ious types of cancer and inflammatory cells, as summarized in
Table 1.
As previously discussed, in response to pancreatic injury,
chemokine production is upregulated leading to infiltration of
leukocytes and stellate cells to the injured acinar cells. Rather lim-
ited information is available on the exact role of Src kinases in
chemokine production in pancreatic inflammation and cancer
(note the question mark in the Figure 1). However, Src kinases
involvement in the secretion of several chemokines was demon-
strated in pancreatic acinar cells (Ramnath et al., 2009) and ductal
cells (Ungefroren et al., 2011). The pretreatment of pancreatic
acini with Src kinase inhibitors markedly decreased MCP-1, MIP-
1, and MIP-2 production after stimulation with the substance-P
(Ramnath et al., 2009). Substance-P is known to play a role
in pathogenesis of cerulein-induced pancreatitis and pancreatic
cancer invasion (Ramnath and Bhatia, 2006; Ito et al., 2007).
Accordingly, it also has been shown that the expression of
CCR5 receptor for MIP-1, MCP-2 and RANTES, is upregu-
lated in chronic pancreatitis in human tissue, as compared with
the healthy pancreas, and the majority of CCR5-positive cells
were infiltrating macrophages (Goecke et al., 2000). Similarly,
the expression of the CCR5 chemokine receptor and its lig-
ands (MIP-1, MCP-2, RANTES) was significantly increased in
themouse pancreas during cerulein-induced pancreatitis (Goecke
et al., 2000; Duell et al., 2006). On the other hand, the SDF-1
chemokine signaling in pancreas and in the other tissues is also
dependent on Src family kinases (Takatomo et al., 2000; Nakata
et al., 2006; Malik et al., 2008). Src family kinases are down-
stream intracellular targets of CXCR4 receptor, and are required
for the SDF-1—mediated cell movement and attachment (Nakata
et al., 2006;Malik et al., 2008). The SDF-1-CXCR4 ligand receptor
axis induces pancreatic cancer cell invasion, and the Src-mediated
SDF-1 signaling is also an obligatory component of pancreatic
regeneration (Takatomo et al., 2000; Kayali et al., 2003; Gao et al.,
2010).
In addition, we have previously shown the SDF-1-CXCR4-
Src signaling axis is crucial for the movement and invasiveness
of inflammatory leukocytes, in a variety of pathological contexts
ranging from inflammation to cancer (Nakata et al., 2006; Chen
et al., 2008; Malik et al., 2008). Several studies have shown that in
human primary leukocytes, Src family members, particularly Lyn
and Lck, are required for CXCR4-dependent cell movement and
infiltration into various inflamed tissues (Inngjerdingen et al.,
2002; Malik et al., 2008). The SDF-1-mediated activation of Lyn
kinase in monocytes, modifies integrin activity through inside-
out signaling, and transiently destabilizes monocyte/endothelial
cell interactions, facilitating full monocyte detachment from
endothelium and penetration into inflamed tissue (Nakata et al.,
2006; Chen et al., 2008; Malik et al., 2008). Importantly, Lyn
is also required for TNF-α and IL-1β production in inflamma-
tory macrophages during stimulation with the CCR5 receptor
ligands (Tomkowicz et al., 2006; Cheung et al., 2008, 2009). The
other Src family members, Src and Hck, have been shown to play
a critical role in IL-6 production in osteoblasts and inflamma-
tory macrophages, respectively (Smolinska et al., 2011; Peruzzi
et al., 2012). IL-6 is required for the maintenance and progres-
sion of pancreatic cancer precursor lesions, and thus is required
for pancreatic cancer growth (Zhang et al., 2013).
In summary, Src family kinases have been demonstrated to be
important in the activation of macrophage, dendritic cells, neu-
trophils and natural killer cells in normal tissues (Ptasznik et al.,
1995, 1996; Abram and Lowell, 2008; Malik et al., 2008). It has
also been shown to control production of cytokine TNF-alpha
stimulated by LPS in normal cells (Orlicek et al., 1999; Sarang
et al., 2011; Okenwa et al., 2013). Thus, Src affects both innate
and adaptive immune responses in normal cells. Consequently,
the elevated and dysregulated Src activity may play a key role
in initiation of the invasive cell phenotype both in infiltrating
immune cells and precancerous cells. However, its most robust
effects are from the production of cytokines and alterations of
cell movement/attachment. In fact, the Src family kinase signal-
ing network is the go between that relay crucial cytokine signals
from inflammatory cells to cancer cells, and conversely, within the
tumor microenvironment (Figure 1). The Src-mediated stimula-
tory effects on malignant cell proliferation and inhibitory effect
on cell death, leads to the accumulation of malignant cells and
thus increases the total mass of the tumor. Consequently, this ele-
vates the production of pro-inflammatory cytokines, including
chemokines, by the tumor which further leads to the recruit-
ment and activation of additional leukocytes that results in a cycle
(as depicted in the Figure 1) leading to cancer development and
progression.
CONCLUDING REMARKS
The Src kinases-dependent signaling that link immune system
with normal tissue plays a vital role in regulating and coordi-
nating immune defense responses. The cross talk between Src
kinase pathways in immune cells and Src kinase-mediated path-
ways in target tissue cells is mediated via cytokine signals elicited
by these cells. These Src-dependent signaling pathways, when
hyper-activated and dysregulated, can lead to the development
of chronic inflammation that predispose to cancer. Src activation
both in infiltrating immune cells and cancer precursor lesions is
driven by pro-inflammatory cytokines within tumor-promoting
microenvironment. This leads to a vicious cycle in which Src
activation increases cytokine production that again induces Src
activation, leading to invasive inflammatory cell and cancer
cell phenotypes. Thus, elucidating the Src-dependent cross talk
signaling mechanisms that link inflammatory cells with cancer
cells, may facilitate the design of new pharmacological agents for
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the concurrent treatment of tumor-promoting inflammation and
cancer. Pancreatic cancer, because of its robust cytokine mediated
interactions between the tumor cells and tumor microenviron-
ment, can be used in designing new agents for the inhibition of
the linkage between inflammation and cancer.
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